Highland Crusader Offshore Partners, L.P.
10% Owner

Highland Crusader Offshore Partners, L.P. insider trades: Angiotech Pharmaceuticals (ANPMF) stock buys and sales

10% Owner, Angiotech Pharmaceuticals Last trade Jun 21, 2012 10 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
10
Open-market trades
since 2006
3
Companies
last trade 2012

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Highland Crusader Offshore Partners, L.P. reports to the SEC

Open-market buys and sales

10 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jun 21, 2012ANPMF↓ Sell$17.2M
Feb 22, 2008SCWH.OB↓ Sell$501.9M
Apr 10, 2007AHOM.OB↑ Buy$16.0M
Apr 9, 2007AHOM.OB↑ Buy$77K
Apr 4, 2007AHOM.OB↑ Buy$145K
Apr 3, 2007AHOM.OB↑ Buy$544K
Mar 29, 2007AHOM.OB↑ Buy$386K
Mar 28, 2007AHOM.OB↑ Buy$1.2M
Mar 27, 2007AHOM.OB↑ Buy$9K
Dec 27, 2006AHOM.OB↑ Buy$210K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Highland Crusader Offshore Partners, L.P.'s insider trades

Highland Crusader Offshore Partners, L.P. is a 10% owner of Angiotech Pharmaceuticals (ANPMF). Since Dec 27, 2006, it has reported 8 open-market purchases worth $18.5M and 2 sales worth $519.1M on SEC Form 4. There have been no open-market trades in the last 12 months.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ANPMF insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.